α6β4 integrin epigenetically upregulates the expression of the stemness marker SOX2 through histone acetylation at the Sox2 promoter site, thereby conferring cisplatin resistance in lung cancer cell lines H520 and SBC5 [100]. The gene discussed is SOX2; the disease is lung carcinoma.